Detalhe da pesquisa
1.
A risk-based postresection follow-up strategy for hepatocellular carcinoma patients.
Cancer
; 129(4): 569-579, 2023 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36541017
2.
An integrated strategy for deciding open versus laparoscopic hepatectomy for resectable primary liver cancer.
BMC Cancer
; 23(1): 193, 2023 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36849920
3.
Survival benefit of liver resection following complete response to transarterial chemoembolization for intermediate-stage hepatocellular carcinoma: a retrospective, multicenter, cohort study.
Int J Surg
; 110(2): 1019-1027, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38006301
4.
Efficacy of additional locoregional therapy based on systemic therapy after intrahepatic progression for BCLC stage B/C hepatocellular carcinoma: A real-world study.
Int Immunopharmacol
; 127: 111413, 2024 Jan 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38118318
5.
Risk of hepatitis B virus reactivation and its effect on survival in advanced hepatocellular carcinoma patients treated with hepatic arterial infusion chemotherapy and lenvatinib plus programmed death receptor-1 inhibitors.
Front Cell Infect Microbiol
; 14: 1336619, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38415009
6.
Patients with hepatocellular carcinoma extrahepatic metastases can benefit from hepatic arterial infusion chemotherapy combined with lenvatinib plus programmed Death-1 inhibitors.
Int J Surg
; 2024 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38549220
7.
Laparoscopic Hepatectomy versus Open Hepatectomy After Conversion Therapy Using Transarterial Chemoembolization or Hepatic Arterial Infusion Chemotherapy for Patients with Initially Unresectable Hepatocellular Carcinoma.
J Hepatocell Carcinoma
; 10: 1157-1167, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37497428
8.
Survival benefit of neoadjuvant hepatic arterial infusion chemotherapy followed by hepatectomy for hepatocellular carcinoma with portal vein tumor thrombus.
Front Pharmacol
; 14: 1223632, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37799969
9.
Levels of pretreatment serum lipids predict responses to PD-1 inhibitor treatment in advanced intrahepatic cholangiocarcinoma.
Int Immunopharmacol
; 115: 109687, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36628893
10.
Survival benefit of preoperative hepatic arterial infusion of oxaliplatin, fluorouracil, and leucovorin followed by hepatectomy for hepatocellular carcinoma.
Front Pharmacol
; 14: 1210835, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37456741
11.
Comparison of hepatic arterial infusion chemotherapy with mFOLFOX vs. first-line systemic chemotherapy in patients with unresectable intrahepatic cholangiocarcinoma.
Front Pharmacol
; 14: 1234342, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37731737
12.
Cholesterol and C-reactive protein prognostic score predicted prognosis of immune checkpoint inhibitors based interventional therapies for intermediate-to-advanced hepatocellular carcinoma patients.
Int Immunopharmacol
; 115: 109651, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36638663
13.
Induction therapy with hepatic arterial infusion chemotherapy enhances the efficacy of lenvatinib and pd1 inhibitors in treating hepatocellular carcinoma patients with portal vein tumor thrombosis.
J Gastroenterol
; 58(4): 413-424, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36894804
14.
Size-Tunable Nanoregulator-Based Radiofrequency Ablation Suppresses MDSCs and Their Compensatory Immune Evasion in Hepatocellular Carcinoma.
Adv Healthc Mater
; 12(30): e2302013, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37665720
15.
Development and Validation of Prognostic Nomograms for Hepatocellular Carcinoma After Hepatectomy Based on Inflammatory Markers.
J Hepatocell Carcinoma
; 9: 1403-1413, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36600988
16.
Antiviral Treatments Eliminate the Adverse Impacts of High Baseline HBV Loads on the Survival of HBV-Related HCC Patients.
J Hepatocell Carcinoma
; 9: 315-325, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35469289
17.
Inflammation-Based Scores Predict Responses to PD-1 Inhibitor Treatment in Intrahepatic Cholangiocarcinoma.
J Inflamm Res
; 15: 5721-5731, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36238770
18.
Tenofovir vs. entecavir on prognosis of hepatitis B virus-related hepatocellular carcinoma after curative resection.
J Gastroenterol
; 57(3): 185-198, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35152312
19.
Preoperative serum ctDNA predicts early hepatocellular carcinoma recurrence and response to systemic therapies.
Hepatol Int
; 16(4): 868-878, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35674872
20.
Comparative safety and efficacy of molecular-targeted drugs, immune checkpoint inhibitors, hepatic arterial infusion chemotherapy and their combinations in advanced hepatocellular carcinoma: findings from advances in landmark trials.
Front Biosci (Landmark Ed)
; 26(10): 873-881, 2021 10 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34719212